167 related articles for article (PubMed ID: 25833769)
1. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
3. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
[TBL] [Abstract][Full Text] [Related]
4. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.
Naleway AL; Gold R; Kurosky S; Riedlinger K; Henninger ML; Nordin JD; Kharbanda EO; Irving S; Cheetham TC; McCarthy NL
Vaccine; 2013 Jun; 31(27):2898-903. PubMed ID: 23639917
[TBL] [Abstract][Full Text] [Related]
5. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
[TBL] [Abstract][Full Text] [Related]
6. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
7. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview.
Charlton R; Snowball J; Sammon C; de Vries C
Therapie; 2014; 69(1):83-9. PubMed ID: 24698192
[TBL] [Abstract][Full Text] [Related]
9. Bias from restricting to live births when estimating effects of prescription drug use on pregnancy complications: A simulation.
Suarez EA; Landi SN; Conover MM; Jonsson Funk M
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):307-314. PubMed ID: 29341340
[TBL] [Abstract][Full Text] [Related]
10. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
11. Deployment Among Active-Duty Military Women and Pregnancy-Related Hypertensive Disorders.
Nash MC; Kip K; Wang W; Custer M; O'Rourke K
Mil Med; 2019 May; 184(5-6):e278-e283. PubMed ID: 30252084
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes following exposure to onabotulinumtoxinA.
Brin MF; Kirby RS; Slavotinek A; Miller-Messana MA; Parker L; Yushmanova I; Yang H
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):179-87. PubMed ID: 26635276
[TBL] [Abstract][Full Text] [Related]
13. The importance of pharmacoepidemiology in pregnancy-implications for safety.
Benevent J; Montastruc F; Damase-Michel C
Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research.
Weaver J; Hardin JH; Blacketer C; Krumme AA; Jacobson MH; Ryan PB
BMC Med Res Methodol; 2023 Oct; 23(1):246. PubMed ID: 37865728
[TBL] [Abstract][Full Text] [Related]
15. Belgian medication exposure during pregnancy (BeMeP), a new nationwide linked database: Linkage methods and prevalence of medication use.
Larcin L; Neven A; Damase-Michel C; Kirakoya-Samadoulougou F
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5705. PubMed ID: 37770071
[TBL] [Abstract][Full Text] [Related]
16. The identification of pregnancies within the general practice research database.
Devine S; West S; Andrews E; Tennis P; Hammad TA; Eaton S; Thorp J; Olshan A
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):45-50. PubMed ID: 19823973
[TBL] [Abstract][Full Text] [Related]
17. Conception and pregnancy during the Persian Gulf War: the risk to women veterans.
Araneta MR; Kamens DR; Zau AC; Gastañaga VM; Schlangen KM; Hiliopoulos KM; Gray GC
Ann Epidemiol; 2004 Feb; 14(2):109-16. PubMed ID: 15018883
[TBL] [Abstract][Full Text] [Related]
18. Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database.
Moll K; Wong HL; Fingar K; Hobbi S; Sheng M; Burrell TA; Eckert LO; Munoz FM; Baer B; Shoaibi A; Anderson S
Drug Saf; 2021 Nov; 44(11):1151-1164. PubMed ID: 34591264
[TBL] [Abstract][Full Text] [Related]
19. Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries.
Tham MY; Ye Q; Ang PS; Fan LY; Yoon D; Park RW; Ling ZJ; Yip JW; Tai BC; Evans SJ; Sung C
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):87-94. PubMed ID: 29108136
[TBL] [Abstract][Full Text] [Related]
20. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
